IntroductionSedation improves patient's satisfaction with endoscopy and also improves quality of the examination. Esophagogastroduodenoscopy (EGD) is a diagnostic technique widely used in the world, and it is more widely used as a screening apparatus of gastric cancer in the East. The use of sedation for EGD varies from country to country and even differs within the same country because of social, cultural, economic, and regulatory influences.Propofol is a short‐acting sedative‐hypnotic drug with a rapid onset of action and rapid recovery profile, and it is easy to use to maintain a proper sedation level. The onset of effect for propofol is 0.5 to 1 min and the duration of effect is 4 to 8 min. However, there are several adverse events, including respiratory depression, hypotension, and pain on injection. Hypotension is resulted from decreased cardiac output and systemic vascular resistance of propofol. With overdosing, respiratory depression generally precedes clinically significant hypotension. Pain on injection is reported by up to 30% of patients, especially when receiving an intravenous bolus of propofol. In addition, there is no existing pharmacologic antagonist recovering from the adverse effects.Midazolam is one of the benzodiazepines that have multiple pharmacologic effects and facilitating sedation for endoscopy. Benzodiazepines have anxiolytic, euphoriant,
Journal of Gastroenterology and Hepatology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera